Preliminary Anticancer Study of Dendrophthoe trigona and Dendrophthoe falcata using Brine Shrimp Lethality Assay

Authors

  • Rakesh E. Mutha H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule (M. S.), Maharashtra, India
  • Piyush S. Bafna H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule (M. S.), Maharashtra, India
  • Ramchandra B. Jadhav Arvind Gavali College of Pharmacy, Satara (M. S.), Maharashtra, India

DOI:

https://doi.org/10.12300/rrjopc.v1i3.408

Abstract

Hemiparasite plants, such as mistletoe, obtains some nourishment from its host and is also photosynthetic to some degree. Despite of their dependence on the host, they are used in treatment of arthritis, urinary disorders, inflammation. The present investigation was aimed at investigating preliminary anticancer potential of ethanolic extract of Dendrophthoe trigona Danser, Loranthaceae and Dendrophthoe falcata Danser, Loranthaceae parasite on Ficus racemosa Linn. Moraceae and Dalbergia paniculata, Fabaceae, respectively. The whole plants were collected, shed dried and powdered for preparation of ethanolic extract. These extracts were used to carry out Brine Shrimp Lethality Assay (BSLA). The total ethanolic extracts show potent cytotoxic activity towards this assay which proves the preliminary anticancer potential of these plant materials.

 

Keywords: Hemiparasite plants, mistletoe, brine shrimp lethality assay

Downloads

Published

2019-03-05

Issue

Vol. 1 No. 3 (2014)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.